Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to evaluate the risk-benefit of a short-term treatment with a low-dose low-molecular-weight heparin (LMWH), in the postpartum period (after delivery). The main quest...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Marc Blondon
NCT06277661 · Postpartum Depression, Postpartum Anxiety, and more
NCT06545760 · Low Birth Weight, Kangaroo Mother Care, and more
NCT07543029 · Breastfeeding, Maternal Role, and more
NCT06312644 · Ultomiris-exposed Pregnant/ Postpartum, Pregnancy, and more
NCT06963047 · Postpartum Period
Geneva University Hospitals
Geneva
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions